Evidence map›Paper›PMID 24737801›Full record

ArticleThe Journal of infectious diseases2014

Estimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens.

Bartholomew N Ondigo, James S Hodges, Kathleen F Ireland, Ng'wena G Magak, David E Lanar, Sheetij Dutta, David L Narum, Gregory S Park, Ayub V Ofulla, Chandy C John

Erratum issuedAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Parasite epidemiology and control · 2024
    Article
  6. Article
  7. Article
  8. Serology reveals micro-differences inFrontiers in parasitology · 2023
    Article
  9. Sensitivity and specificity for malaria classification of febrile persons by rapid diagnostic test, microscopy, parasite DNA, histidine-rich protein 2, and IgG: Dakar, Senegal 2015.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Spatial, environmental, and individual associations withFrontiers in cellular and infection microbiology · 2022
    Article
  16. Article
  17. Antibody Profiles toThe American journal of tropical medicine and hygiene · 2020
    Article
  18. Antibody Correlates of Protection from ClinicalThe American journal of tropical medicine and hygiene · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Bartholomew N OndigoDepartment of Biomedical Science and Technology, Maseno University Center for Global Health Research, Kenya Medical Research Institute, Kisumu.
James S HodgesDivision of Biostatistics, School of Public Health, University of Minnesota.
Kathleen F IrelandDepartment of Pediatrics, University of Minnesota Medical School.
Ng'wena G MagakDepartment of Medical Physiology, Maseno University, Kenya.
David E LanarCenter for Global Health Research, Kenya Medical Research Institute, Kisumu.
Sheetij DuttaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu.
David L NarumMalaria Vaccine Branch, Walter Reed Army Institute for Research, Silver Spring.
Gregory S ParkLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland.
Ayub V OfullaLaboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institute of Health, Rockville, Maryland.
Chandy C JohnDepartment of Pediatrics, University of Minnesota Medical School Center for Global Health Research, Kenya Medical Research Institute, Kisumu.

Funding

Mali International Center for Excellence in Research: Malaria Clinical ResearchZIAAI001056 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2024
$43.1M
Vaccines to Interrupt Malaria Transmission: Discovery and AssaysZIAAI001007 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DUFFY, PATRICK · 2009 to 2025
$28.9M
Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
Malaria transmission and immunity in highland KenyaU01AI056270 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI JOHN, CHANDY C. · 2005 to 2009
$2.9M
FIC NIH HHS D43 TW0080085FIC NIH HHS R25 TW009345Intramural NIH HHSNIAID NIH HHS U01 AI056270
6 · The paper itself

Abstract

backgroundTools that estimate recent and long-term malaria transmission in a population would be highly useful for malaria elimination programs.

methodsThe prevalence of antibodies to 11 Plasmodium falciparum antigens was assessed by cytometric bead assay or enzyme-linked immunosorbent assay in 1000 people in a highland area of Kenya over 14 months, during a period of interrupted malaria transmission.

resultsAntibodies differed by antigen in acquisition with age: rapid (>80% antibody positive by age 20 years, 5 antigens), moderate (>40% positive by age 20 years, 3 antigens), or slow (<40% positive by age 20 years, 3 antigens). Antibody seroreversion rates in the 14 months between samples decreased with age rapidly (7 antigens), slowly (3 antigens), or remained high at all ages (schizont extract). Estimated antibody half-lives in individuals >10 years of age were long (40 to >80 years) for 5 antigens, moderate (5-20 years) for 3 antigens, and short (<1 year) for 3 antigens.

conclusionsAntibodies to P. falciparum antigens in malaria-endemic areas vary by age, antigen, and time since last exposure to P. falciparum. Multiplex P. falciparum antibody testing could provide estimates of long-term and recent malaria transmission and potentially of a population's susceptibility to future clinical malaria.

Indexed as

AdolescentAdultAgedAged, 80 and overAge FactorsAntibodies, ProtozoanAntigens, ProtozoanChildChild, PreschoolCohort StudiesFemaleHumansImmunoassayInfantKenyaMalaria, FalciparumAntibodies, ProtozoanAntigens, Protozoanantibodyeliminationhalf-lifemalariaPlasmodium falciparum

Identifiers

PMID24737801
PMCPMC4168304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.